Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Farmer left with £40K bill to remove waste left by flytippers Trump sends fighter jet squadron to 'kick the door down' in Iran Council worker who stole £900K from benefit claimants jailed 'Vampire' ...

February 17 - Recently acquired Utah Jazz forward Jaren Jackson Jr. had successful surgery on Tuesday to remove a growth in his left knee, the team announced. The Jazz said Jackson, 26, will begin ...

Utah's new big man will be re-evaluated in 4 weeks to determine his recovery status. The Associated Press Jaren Jackson Jr. was acquired by Utah in a trade with Memphis before the trade deadline. SALT ...

SALT LAKE CITY — Utah Jazz forward Jaren Jackson Jr. underwent surgery on Tuesday to remove a growth in his left knee. The Jazz said Jackson will begin rehabilitation and be re-evaluated in four weeks ...

Instagram is developing a feature that will allow users to remove themselves from someone’s “Close Friends” list, Meta told TechCrunch on Friday. The company says the feature is still in the early ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...